Hepatitis B and C co-infection represents a challenging therapeutic conundrum. Due to the increasing rate of hepatitis C infection in the population, treatment of hepatitis C (often with cirrhosis) in the face of co-morbid psychiatric illness is an increasingly common clinical challenge. Literature on the diagnosis, treatment and public health issues related to hepatitis B and hepatitis C co-infection and their management in major psychiatric illness is reviewed. Practical issues associated with compliance, adverse drug reactions, and the use of growth factors and psychotropic medications to control comorbid and/or treatment-emergent psychiatric disorders in viral hepatitis are discussed.
|Original language||English (US)|
|Number of pages||11|
|State||Published - Jun 2007|
ASJC Scopus subject areas